In this study, we conducted a comprehensive analysis of the associations between SPIN1 expression and various factors, including tumor progression, clinical stage, immune microenvironment, drug sensitivity and epigenetic regulation in a cohort of 375 GC patients and 32 controls. The gene discussed is SPIN1; the disease is gastric cancer.